In summary, it was originally unearthed through this experiment that silencing of LINC01857 could alleviate HCC malignancy by participating in the ceRNA interaction to upregulate miR-197-3p and inactivate AGR2, thereby downregulating the AKT and ERK pathways. Here, AKT1 is linked to hepatocellular carcinoma.